A pharmaceutical formulation for SARS-cov-2 infection

MYPI2025001208A0Pending Publication Date: 2026-08-20NATIONAL UNIVERSITY OF MALAYSIA

0 Cites 0 Cited by

Patent Information

Application Number: MYPI2025001208
Authority / Receiving Office: MY · MY
Patent Type: Applications
Current Assignee / Owner
Filing Date: 2025-02-20
Publication Date: 2026-08-20

Application Information

Patent Timeline

20 Feb 2025

Application

MYPI2025001208

20 Aug 2026

Publication

MYPI2025001208A0

Inventors: MOHD CAIRUL IQBAL BIN MOHD AMIN; NUR NAJIHAH ‘IZZATI BINTI MAT RANI

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention relates to a pharmaceutical formulation for SARS-CoV- 2 infection comprising an immunoliposome serving as a nanocarrier. The pharmaceutical further comprises an antiviral agent for inhibiting SARS-CoV-2 replication, a first antibody for neutralising SARS-CoV-2 viral particles, and a second antibody for inhibiting vascular endothelial growth factor.

Need to check novelty before this filing date? Find Prior Art